ArticleDrug delivery2022

Delivery of human natural killer cell-derived exosomes for liver cancer therapy: an in vivo study in subcutaneous and orthotopic animal models.

Ho Yong Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.